Health systems across the country are making it easier for primary care clinicians to order genetic tests for patients who ...

AI-driven genomics startups leverage technology to analyze genetic data, predict predispositions, and offer personalized ...

The company, founded by 25-year-old Kian Sadeghi, announced a $14 million Series A, bringing its total funding to about $32 million.

While genetic testing rates for advanced ovarian cancer have increased, gaps in physician understanding and confidence in interpreting results may limit optimal biomarker-driven treatment and patient ...

After a genetic test, Alex Swanson learned he has hereditary hemochromatosis, a condition causing iron overload that can lead ...

Rates of genetic testing for autism and intellectual and development disorders were associated with race, gender, and insurance company.

SALT LAKE CITY - Myriad Genetics , Inc. (NASDAQ: NASDAQ:MYGN), a company specializing in genetic testing and precision medicine with annual revenues of $824 million, has announced the issuance of two ...

Significant racial disparities persisted in genetic testing for inborn errors of immunity despite the removal of financial ...

Mallards over the 30 percent farm-raised DNA threshold are showing poor migration habits The author's drake mallard and three ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

Researchers from The Institute of Cancer Research in London have developed a new test that can predict colorectal cancer risk ...

AlleyWatch sat down with Nucleus CEO and Founder Kian Sadeghi to learn more about the business, its future plans, and recent ...